Products Search

 

Industry Insight - Delivering valuable information to the healthcare & engineering communities

In the News

Industry Publications Tap NuSil Expertise

As an industry leader, NuSil is often asked to contribute bylined articles or provide its expert viewpoints to top-tier publications. Two recent articles include "Silicones In Medical Electronics," featured in the January/February 2008 edition of Medical Device Technology, and " Silicones Show It's Okay to Be Passive" in the April 2008 issue of Medical Product Manufacturing News.

"Silicones In Medical Electronics" discusses silicone's bioinert uses in healthcare applications, as well as how the material's unique properties make it ideal for use in electronic devices. On the other hand, "Silicones Show It's Okay to Be Passive," addresses the importance of finding the right material to optimize passive drug delivery applications.

Back to top

Silicone Materials Series

Troubleshooting Silicone Materials Series:
Eliminating Bubbling Or Porosity

Bubbling (porosity) in silicone materials can adversely affect cured silicone material properties, including tensile, tear, elongation and appearance. Design and process engineers seeking to reduce or eliminate bubbles are encouraged to characterize the phenomenon as primarily process- and/or material-related. Both can contribute to bubbling, but changing one variable may eliminate the problem.

Process

The first stage of most silicone molding, dipping, wiping or potting processes is the preparation of the material for cure. Two-part silicone systems require mixing to cure. While automated processes can complete this stage without introducing air into the system, they should be periodically inspected to ensure this is the case.

Hand- or machine-mixing in an open air environment will introduce air to the silicone, requiring the removal of the entrapped air by vacuum or centrifuge. NuSil finds de-airing to be the most effective means of reducing air and other gasses that can cause bubbling. The transfer of the silicone, mixed or not, to the curing area, surface or mold needs to be designed to avoid air introduction.

Mold or cure area design is also critical to bubble elimination. Closed-mold designs must avoid bubble creation or entrapment. Venting of the mold and other techniques are effective at producing bubble-free molded part(s). NuSil can provide a list of equipment manufacturers that provide help in these areas.

Processing conditions, from room temperature to injection port temperature, are just a few examples of where temperatures should be closely monitored. In molding processes, the injection pressure can play a significant role in bubble reduction.

Material

During cure, silicone materials that undergo crosslinking contain reactive species. Bubbling can arise from reactive components interacting with nearby substrates or even cleaning materials. Therefore, evaluating substrate surfaces in the design phase is an important step in eliminating incompatibility. Cleaning procedures should remove virtually all traces of solvents and other liquids that may volatilize in a heated curing process. The cure time and temperature of silicone materials can be adjusted to minimize bubbling (e.g., if a substrate outgases at high temperatures, a room-temperature or low-temperature curing silicone can eliminate bubbling).

Processes, substrates and silicone materials differ for each situation; therefore, any bubbling situation requires a specific solution. Contact your local technical representative if you have specific questions. You may find your representative’s contact information here.

Back to top

New Products & Developments

NuSil Unveils Water-Resistant Dimethicone

NuSil recently announced the launch of its MED-323 dimethicone product. MED-323, a tri-methyl endblocked polydimethylsiloxane, may be considered as an excipient for cosmetic and pharmaceutical applications and offers excellent water repellency in topical skin and hair care products. It meets the requirements of the United States Pharmacopeia National Formulary (NF) and European Pharmacopeia (EP) for a dimethicone at 350 cSt viscosity. In addition, the product is produced in NuSil's FDA-registered manufacturing site.

For more information, visit http://www.nusil.com/ or contact Brian Reilly, Product Director - Healthcare Materials, at 805-684-8780 or New Products & Developments.

Back to top